Poster Presentation: Impact of Preoperative Assessment for Patients on Buprenorphine, Methadone, and Naltrexone

Availability

On-Demand

Expires on 02/20/2025

Cost

$0.00

Credit Offered

0.25 Class A Credit

Despite the recognized benefits of Pre-Operative Evaluation (POE) clinic assessments, their impact on patients using methadone, buprenorphine, or naltrexone for chronic pain or substance use disorder (SUD) remains underexplored. These patients present unique perioperative challenges due to the complex pharmacology of these medications, and deviations from evolving perioperative recommendations can lead to difficult pain management and suboptimal outcomes.

This course focuses on optimizing POE clinic assessments for this patient population. Participants will gain insights into current guidelines and the importance of incorporating non-opioid multimodal analgesic strategies. By standardizing POE practices, anesthesia providers will receive valuable guidance to enhance preoperative planning, improve perioperative outcomes, and increase patient satisfaction.

Learning Outcomes:

Identify the impacts of POE clinic assessments on patients utilizing methadone, buprenorphine, and naltrexone for either chronic pain or SUD.
Assess the utilization of POE clinical assessments prior to surgical procedures in patients utilizing methadone, buprenorphine or naltrexone for chronic pain or SUD at a large tertiary medical center.

This program has been prior approved by the American Association of Nurse Anesthesiology for 0.25 Class A CE credits; Code Number 1044776; Expiration Date 2/20/2025.

Addyson E. Sand, BSN, SRNA
Helen T. Marry, BSN, SRNA
Heather R. Rathbun, BSN, SRNA
JEnna R. Steege, APRN, CRNA, DNP
Allison LeMahieu, MS
Oludare O. Olatoye, MD

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.